Clinical Trials Directory

Trials / Unknown

UnknownNCT03607383

Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Saint-Joseph University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Detailed description

Red yeast rice is a source of active compounds in reducing LDL levels with practically no side effects. Studies performed on American and Chinese populations have shown positive results. These studies need confirmation in different populations. Molval Fort is a natural product available in the Lebanese market with a combination of red yeast rice extracts, EPA/DHA and coenzyme Q10. The investigators are conducting this study to explore the effect of red yest rice extracts based product on LDL and its side effects in a sample of primary care Lebanese patients.

Conditions

Interventions

TypeNameDescription
DRUGRed Rice Yeast Extractadults requiring moderate intensity treatment will be provided red rice yeast extracts or statins, depending on the randomization; followed for compliance and adverse effects check, and reevaluated in a final visit with blood test after 8 weeks
DRUGStatinStatin choice is done at the discretion of the treating physician for a moderate intensity treatment equivalent according the American College of Cardiology/American Heart Association (ACC/AHA) guidelines definitions, for 8 weeks

Timeline

Start date
2018-02-07
Primary completion
2020-04-30
Completion
2020-04-30
First posted
2018-07-31
Last updated
2019-10-08

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT03607383. Inclusion in this directory is not an endorsement.